Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

A Ly; H T Duc; M Kalamarides; L A Trojan; Y Pan; A Shevelev; J C François; T Noël; A Kane; D Henin

doi:10.1136/mp.54.4.230

Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Identifier:nobleid.org/w1/20260515/CE7A8FD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE7A8FD3.svg?ark=w1%2F20260515%2FCE7A8FD3)](https://nobleid.org/work/w1/20260515/CE7A8FD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Identifier:nobleid.org/w1/20260515/CE7A8FD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE7A8FD3.svg?ark=w1%2F20260515%2FCE7A8FD3)](https://nobleid.org/work/w1/20260515/CE7A8FD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work